TY - JOUR
T1 - Alpha-Synuclein Oligomers Interact with Metal Ions to Induce Oxidative Stress and Neuronal Death in Parkinson's Disease
AU - Deas, Emma
AU - Cremades, Nunilo
AU - Angelova, Plamena R
AU - Ludtmann, Marthe H R
AU - Yao, Zhi
AU - Chen, Serene
AU - Horrocks, Mathew H
AU - Banushi, Blerida
AU - Little, Daniel
AU - Devine, Michael J
AU - Gissen, Paul
AU - Klenerman, David
AU - Dobson, Christopher M
AU - Wood, Nicholas W
AU - Gandhi, Sonia
AU - Abramov, Andrey Y
PY - 2016/3/1
Y1 - 2016/3/1
N2 - AIMS: Protein aggregation and oxidative stress are both key pathogenic processes in Parkinson's disease, although the mechanism by which misfolded proteins induce oxidative stress and neuronal death remains unknown. In this study, we describe how aggregation of alpha-synuclein (α-S) from its monomeric form to its soluble oligomeric state results in aberrant free radical production and neuronal toxicity.RESULTS: We first demonstrate excessive free radical production in a human induced pluripotent stem-derived α-S triplication model at basal levels and on application of picomolar doses of β-sheet-rich α-S oligomers. We probed the effects of different structural species of α-S in wild-type rat neuronal cultures and show that both oligomeric and fibrillar forms of α-S are capable of generating free radical production, but that only the oligomeric form results in reduction of endogenous glutathione and subsequent neuronal toxicity. We dissected the mechanism of oligomer-induced free radical production and found that it was interestingly independent of several known cellular enzymatic sources.INNOVATION: The oligomer-induced reactive oxygen species (ROS) production was entirely dependent on the presence of free metal ions as addition of metal chelators was able to block oligomer-induced ROS production and prevent oligomer-induced neuronal death.CONCLUSION: Our findings further support the causative role of soluble amyloid oligomers in triggering neurodegeneration and shed light into the mechanisms by which these species cause neuronal damage, which, we show here, can be amenable to modulation through the use of metal chelation.
AB - AIMS: Protein aggregation and oxidative stress are both key pathogenic processes in Parkinson's disease, although the mechanism by which misfolded proteins induce oxidative stress and neuronal death remains unknown. In this study, we describe how aggregation of alpha-synuclein (α-S) from its monomeric form to its soluble oligomeric state results in aberrant free radical production and neuronal toxicity.RESULTS: We first demonstrate excessive free radical production in a human induced pluripotent stem-derived α-S triplication model at basal levels and on application of picomolar doses of β-sheet-rich α-S oligomers. We probed the effects of different structural species of α-S in wild-type rat neuronal cultures and show that both oligomeric and fibrillar forms of α-S are capable of generating free radical production, but that only the oligomeric form results in reduction of endogenous glutathione and subsequent neuronal toxicity. We dissected the mechanism of oligomer-induced free radical production and found that it was interestingly independent of several known cellular enzymatic sources.INNOVATION: The oligomer-induced reactive oxygen species (ROS) production was entirely dependent on the presence of free metal ions as addition of metal chelators was able to block oligomer-induced ROS production and prevent oligomer-induced neuronal death.CONCLUSION: Our findings further support the causative role of soluble amyloid oligomers in triggering neurodegeneration and shed light into the mechanisms by which these species cause neuronal damage, which, we show here, can be amenable to modulation through the use of metal chelation.
KW - Amyloid beta-Peptides/metabolism
KW - Animals
KW - Apoptosis
KW - Caspase 3/metabolism
KW - Caspase 7/metabolism
KW - Cell Differentiation
KW - Enzyme Activation
KW - Gene Duplication
KW - Glutathione/metabolism
KW - Humans
KW - Induced Pluripotent Stem Cells/cytology
KW - Ions/metabolism
KW - Metals/metabolism
KW - Neurons/cytology
KW - Oxidative Stress
KW - Parkinson Disease/genetics
KW - Protein Aggregation, Pathological
KW - Protein Conformation
KW - Protein Multimerization
KW - Rats
KW - Reactive Oxygen Species/metabolism
KW - Structure-Activity Relationship
KW - alpha-Synuclein/chemistry
U2 - 10.1089/ars.2015.6343
DO - 10.1089/ars.2015.6343
M3 - Article
C2 - 26564470
SN - 1523-0864
VL - 24
SP - 376
EP - 391
JO - Antioxidants & Redox Signaling
JF - Antioxidants & Redox Signaling
IS - 7
ER -